Navigation Links
BioGenex Completes Construction of a State-of-the-Art Center for Cancer Diagnostics and Molecular Pathology Innovation in Hyderabad, India
Date:2/16/2016

FREMONT, Calif., Feb. 16, 2016 /PRNewswire/ -- BioGenex, a global leader and innovator in providing customer-centric molecular pathology solutions, complete walk-away kits and automation for diagnosis, prognosis, and therapy selection for cancer, is pleased to announce the completion of the Phase I Construction of the Center of Excellence in Hyderabad, India. The 100,000-SqFt Center of Excellence is located on a 20-acre site in the Special Economic Zone (SEZ) of Hyderabad, a large business hub located right off the Outer Ring Road- a 158 kilometer expressway allowing speeds up to 120km/hr. This centralized location and proximity to RGI Airport, a short 35-minute drive away, allows for more efficient international business transactions. This new township will have over 40,000 employees by the end of 2016. TCS (Tata Consultancy) and TATA Advance Systems are among other major institutions building large facilities in the area. BioGenex will use this facility for design and development of multiple new molecular pathology systems and for manufacturing of Xmatrx family instruments. As part of our phased transition, BioGenex's instrument manufacturing, supply chain, stock rooms, R&D, engineering, and QA departments have already moved into the facility.

Photo - http://photos.prnewswire.com/prnh/20160215/333139

Though the facility aims to provide support to both domestic and international markets, global exports will be the key focus area. To help meet the demands of the growing business, the new facility houses complete manufacturing capability for BioGenex's suite of molecular pathology work systems along with the supporting reagents and consumables. The facility also allows for expanded training for our international and domestic distributors and customers.

"This is an important move for BioGenex to ensure that we understand our customer's requirements and tailor our products to meet their needs. Our location in Hyderabad establishes a regional presence with global support capabilities to provide timely product delivery, enhance technical support, complete laboratory set-up for training and to facilitate new product development and launch," said Dr. Krishan Kalra, CEO of BioGenex.

At BioGenex we are committed to providing products and instruments for Molecular Pathology clinical and research. This is one of the steps we are taking to fulfill that commitment.

For more information visit www.biogenex.com

New Facility Address
Aerospace & Precision Engineering SEZ
Hyderabad, India 
Click for directions

About BioGenex

BioGenex designs, develops, and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of our eFISHency integrated workflow solution for FISH laboratories and miRNA system for characterization of CUP and for undifferentiated tumors is a game changer that has no rival in the industry. Our fully-automated molecular pathology workstations are the most advanced system globally. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest systems for life Science research and diagnostics.

Visit us at www.biogenex.com

Contact Information
Jay Kishan
49026 Milmont Drive; Fremont, CA 94538
Tel: +1-510-824-1442; Email 
Website: www.biogenex.com


'/>"/>
SOURCE BioGenex Laboratories
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. BGI-Shenzhen Completes Acquisition of Complete Genomics
2. Novira Therapeutics Completes $25 Million Series A Financing
3. bioRASI Completes Acquisition of Ukrainian CRO
4. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
5. St. Mary Completes Phase 2 of Its Emergency Department and Trauma Center Expansion
6. Leviticus Cardio Ltd. Completes a Successful Animal Trial for its Wireless Energy System for VADs
7. Oligomerix, Inc. Completes Series B Financing
8. Eurofins MWG Operon Quality Assurance Group Completes ISO Certifications for Their New Overnight Sequencing Lab
9. SureClinical Completes FDA 21 CFR Part 11 Compliance Audit of SureTrial® eTMF Cloud Edition
10. Boston Scientific Completes $1.05 Billion Senior Notes Offering
11. VIVEX BIOMEDICAL Successfully Completes $7.6 Million Round of Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... They call it the “hairy ball.” ... depiction of a system of linkages and connections so complex and dense that ... computer science at Worcester Polytechnic Institute (WPI) and director of the university’s bioinformatics ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
Breaking Biology News(10 mins):